Cochlear implantation in children with auditory neuropathy: Lessons from Brown–Vialetto–Van Laere syndrome
Open Access
- 18 October 2018
- journal article
- research article
- Published by Taylor & Francis in Cochlear Implants International
- Vol. 20 (1) , 31-38
Abstract
Objective: Brown–Vialetto–Van Laere syndrome (BVVL) is a rare neurodegenerative disorder associated with auditory neuropathy (AN). The decision process for CI in AN is evolving with increasing evidence of efficacy. We evaluated the benefit of CI in children with BVVL syndrome. Methods: A retrospective study reviewed the pre- and post-operative hearing outcomes of three patients with BVVL who presented for CI. A fourth patient with BVVL who was not suitable for CI is also discussed. The primary outcomes were hearing thresholds and auditory perception. Outcome measurement instruments included visual reinforcement audiometry (VRA) or Play Audiometry (PA), Categories of Auditory Performance (CAP) and Auditory Speech Sound Evaluation (ASSE). Secondary outcomes were parental report (BAPP questionnaire), the perception of our SaLT and compliance. Results: Patient 1 had ASSE levels of 40–45 dB HL 1 year post-operatively, and CAP score had improved from 2 to 5. At 2-year review, aided thresholds were 40 dB at 2–4 kHz. Three months following CI, the CAP score of Patient 2 had improved from 3 to 5. At 6 months, thresholds were 25–30 dB at 2–4 kHz. Single words/phrases are used by both patients and benefit is reported by both families. Patient 3 has recently undergone CI, having been previously rejected at another centre. Three months following CI, his thresholds were 35–40 dB at 2–4 kHz and increased use of sign and vocalization is reported. Conclusion: CI in children with AN complicating BVVL has a variable, but a positive effect. Other manifestations of BVVL make measuring benefit challenging, in the absence of a ‘bespoke’ measurement instrument for children with complex needs. This study provides further evidence for the benefit of CI in children with AN.Keywords
This publication has 21 references indexed in Scilit:
- Impaired riboflavin transport due to missense mutations in SLC52A2 causes Brown‐Vialetto‐Van Laere syndromeJournal of Inherited Metabolic Disease, 2012
- Auditory neuropathiesCurrent Opinion in Neurology, 2012
- The Brown-Vialetto-Van Laere and Fazio Londe syndrome revisited: natural history, genetics, treatment and future perspectivesOrphanet Journal of Rare Diseases, 2012
- Maternal riboflavin deficiency, resulting in transient neonatal-onset glutaric aciduria Type 2, is caused by a microdeletion in the riboflavin transporter gene GPR172BHuman Mutation, 2010
- Cochlear Implantation in Brown–Vialetto–Van-Laere syndromeThe Journal of Laryngology & Otology, 2010
- Cochlear Implantation in Children with Auditory Neuropathy Spectrum DisorderEar & Hearing, 2010
- Brown-Vialetto-Van Laere Syndrome, a Ponto-Bulbar Palsy with Deafness, Is Caused by Mutations in C20orf54The American Journal of Human Genetics, 2010
- Frequency-Specific Electrocochleography Indicates that Presynaptic and Postsynaptic Mechanisms of Auditory Neuropathy ExistEar & Hearing, 2008
- Brown-Vialetto-Van Laere SyndromeNeuropathology and Applied Neurobiology, 1993
- Ponto-bulbar palsy with deafness (Brown-Vialetto-Van Laere syndrome)Journal of the Neurological Sciences, 1981